Basal Cell Carcinoma News and Research

RSS
Basal cell cancer begins in the lowest layer of the epidermis, the basal cell layer. About 8 out of 10 skin cancers are basal cell carcinomas. They usually begin on areas exposed to the sun, such as the head and neck. Basal cell carcinoma was once found mostly in middle-aged or older people. But now it is also being seen in younger people. This may be because people are spending more time in the sun without protecting their skin.

Basal cell carcinoma tends to grow slowly. It is very rare for a basal cell cancer to spread to distant parts of the body (metastasize). But if it is not treated, it can grow into nearby areas and spread into the bone or other tissues beneath the skin.

After treatment, basal cell carcinoma can come back (recur) in the same place on the skin. New basal cell cancers can also start in other places on the skin. As many as half of the people who have one basal cell cancer will get a new skin cancer within 5 years.
Leukemia drug appears to be effective in treating deadly pediatric brain tumor

Leukemia drug appears to be effective in treating deadly pediatric brain tumor

Study identifies key epigenetic regulator that controls skin cell turnover

Study identifies key epigenetic regulator that controls skin cell turnover

New Milford Hospital’s Eating Well program offers comfort to patients and caregivers

New Milford Hospital’s Eating Well program offers comfort to patients and caregivers

GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

Limiting UV exposure is the number one way to reduce rising female skin cancer rates

Limiting UV exposure is the number one way to reduce rising female skin cancer rates

Research sheds light on sun-induced DNA damage and repair

Research sheds light on sun-induced DNA damage and repair

GW researchers underscore need for tailored skin cancer prevention programs

GW researchers underscore need for tailored skin cancer prevention programs

Wear protective clothing to reduce the risk of skin damage from sun's UV rays

Wear protective clothing to reduce the risk of skin damage from sun's UV rays

Artificial intelligence better than humans in diagnosing pigmented skin lesions

Artificial intelligence better than humans in diagnosing pigmented skin lesions

Research identifies super-enhancers as novel target for pancreatic ductal adenocarcinoma

Research identifies super-enhancers as novel target for pancreatic ductal adenocarcinoma

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

Financial difficulties add to patients' cancer struggle

Financial difficulties add to patients' cancer struggle

Skin cancer rates 350% more than previous estimates suggested, new UK database reveals

Skin cancer rates 350% more than previous estimates suggested, new UK database reveals

Check your medical records for dangerous errors

Check your medical records for dangerous errors

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

Advanced microscopes determine structure of molecular complex implicated in several cancers

Advanced microscopes determine structure of molecular complex implicated in several cancers

Researchers compare existing approaches for automating diagnostic procedures of skin lesions

Researchers compare existing approaches for automating diagnostic procedures of skin lesions

AAD releases new guidelines of care for management of nonmelanoma skin cancer

AAD releases new guidelines of care for management of nonmelanoma skin cancer

Study shows connection between common hypertension drug and skin cancer

Study shows connection between common hypertension drug and skin cancer

Xstrahl receives FDA 510 (k) clearance for marketing its Photoelectric Therapy System

Xstrahl receives FDA 510 (k) clearance for marketing its Photoelectric Therapy System